Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats (Jul, 10.1007/s13318-021-00697-x, 2021)
| dc.contributor.author | Şahin, Kazım | |
| dc.contributor.author | Küçük, Ömersman | |
| dc.contributor.author | Orhan, Cemal | |
| dc.contributor.author | Sahin, Emre | |
| dc.contributor.author | Fowler, Kelli | |
| dc.contributor.author | White, Tyler | |
| dc.contributor.author | Bellamine, Aouatef | |
| dc.date.accessioned | 2026-08-12T17:19:46Z | |
| dc.date.issued | 2021 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.doi | 10.1007/s13318-021-00710-3 | |
| dc.identifier.endpage | 651 | |
| dc.identifier.issn | 0378-7966 | |
| dc.identifier.issn | 2107-0180 | |
| dc.identifier.issue | 5 | |
| dc.identifier.orcid | 0000-0003-4138-7689 | |
| dc.identifier.orcid | 0000-0001-9542-5244 | |
| dc.identifier.orcid | 0000-0001-7625-1883 | |
| dc.identifier.orcid | 0000-0003-0162-5865 | |
| dc.identifier.orcid | 0000-0002-2646-2479 | |
| dc.identifier.pmid | 34420203 | |
| dc.identifier.scopus | 2-s2.0-85113265835 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 651 | |
| dc.identifier.uri | https://doi.org/10.1007/s13318-021-00710-3 | |
| dc.identifier.uri | https://hdl.handle.net/11508/53316 | |
| dc.identifier.volume | 46 | |
| dc.identifier.wos | WOS:000687111900001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Springer France | |
| dc.relation.ispartof | European Journal of Drug Metabolism and Pharmacokinetics | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.title | Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats (Jul, 10.1007/s13318-021-00697-x, 2021) | |
| dc.type | Correction |
